Selicrelumab

Selicrelumab Suppliers list
Company Name: Aladdin Scientific
Tel:
Email: tp@aladdinsci.com
Products Intro: Product Name:Selicrelumab (anti-CD40)
CAS:1622140-49-1
Purity:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human I Package:$119.9/100μg;$579.9/1mg;$1449.9/5mg;$2319.9/10mg;Bulk package Remarks:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354
Email: marketing@targetmol.com
Products Intro: Product Name:Selicrelumab
CAS:1622140-49-1
Package:1mg;243USD|5mg;589USD|10mg;842USD
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 021-61312847; 18021002903
Email: 3008007409@qq.com
Products Intro: Product Name:Selicrelumab (anti-CD40)
CAS:1622140-49-1
Purity:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human I Package:5mg Remarks:K10723
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Email: 2853530910@QQ.com
Products Intro: Product Name:Selicrelumab
CAS:1622140-49-1
Purity:95% Package:100ug;500ug;1mg
Company Name: Guangzhou Hongyuan Chemical Co.,Ltd  
Tel: 15817493340
Email: 981810490@qq.com
Products Intro: Product Name:Selicrelumab
CAS:1622140-49-1
Purity:95% Package:1mg;1g;100g

Selicrelumab manufacturers

  • Selicrelumab
  • Selicrelumab pictures
  • $193.00 / 1mg
  • 2025-09-17
  • CAS:1622140-49-1
  • Min. Order:
  • Purity: 98.7% (SDS-PAGE); 95.2% (SEC-HPLC)
  • Supply Ability: 10g
Selicrelumab Basic information
Product Name:Selicrelumab
Synonyms:Selicrelumab;Research Grade Selicrelumab(DHD68903);Selicrelumab (anti-CD40);Research Grade Selicrelumab
CAS:1622140-49-1
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Selicrelumab Structure
Selicrelumab Chemical Properties
form Liquid
color Colorless to light yellow
Safety Information
MSDS Information
Selicrelumab Usage And Synthesis
UsesSelicrelumab is an agonist CD40 antibody, induces changes in the tumor microenvironment. Selicrelumab can be used for the research of pancreatic cance and neoadjuvant study[1].
References[1] Katelyn T Byrne, Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer. Clin Cancer Res. 2021 Aug 15;27(16):4574-4586. DOI:10.1158/1078-0432.CCR-21-1047
Selicrelumab Preparation Products And Raw materials
Tag:Selicrelumab(1622140-49-1) Related Product Information
Oleclumab ipilimumab Cusatuzumab Dacetuzumab Cibisatamab Galcanezumab Rovalpituzumab Tinurilimab Zolbetuximab Eculizumab

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.